Cargando…
Target dIsease-Guided placEbo-contRolled (TIGER) design: a novel method for clinical trials of acupuncture
BACKGROUND: At present, the design of an ideal placebo control in acupuncture studies challenges researchers. Previously devised sham acupuncture techniques have reported various imperfections; therefore, the specific effects of acupuncture cannot be accurately examined in clinical trials primarily...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816100/ https://www.ncbi.nlm.nih.gov/pubmed/24168427 http://dx.doi.org/10.1186/1745-6215-14-359 |
_version_ | 1782289493630386176 |
---|---|
author | Zheng, Wenke Wang, Hui Zhang, Li Bian, Zhaoxiang Shang, Hongcai |
author_facet | Zheng, Wenke Wang, Hui Zhang, Li Bian, Zhaoxiang Shang, Hongcai |
author_sort | Zheng, Wenke |
collection | PubMed |
description | BACKGROUND: At present, the design of an ideal placebo control in acupuncture studies challenges researchers. Previously devised sham acupuncture techniques have reported various imperfections; therefore, the specific effects of acupuncture cannot be accurately examined in clinical trials primarily because of interferences from the placebo effects. METHOD: Guided by evidence-based medicine (EBM) theories, we have made an initial attempt to establish a set of control methods for use in acupuncture studies, which is named the target disease-guided placebo-controlled (TIGER) design. In a trial using the TIGER design, participants suffering simultaneously from a predefined target disease and a pseudo target disease will be recruited and randomized to receive identical acupuncture intervention measures. As a result, the interventions not only appear the same but also produce the same stimulations in both groups. The patients in the treatment group will be informed of the actual target disease that the treatment aims for, whereas patients in the control group will be informed that the treatment is for the pseudotarget disease. It is speculated that no psychological response will be aroused in the control group. During data analysis, changes in the outcome measures of the patients in the control groupreveal the real therapeutic effect of acupuncture, and those of patients in the treatment group show both the real and placebo acupuncture effect. In this article, we explain how to put this design into use in a planned randomized clinical trial of acupuncture for the treatment of migraine. RESULTS: This approach can eliminate the acupuncture placebo effect in the control group that may confound trial results. It is possible to observe the specific and placebo effects of acupuncture for the target disease separately using the TIGER design. CONCLUSIONS: The proposed TIGER design has limitations. It is designed for clinical studies focusing on the specific effects of acupuncture, and it needs to be tested and verified for practicality and feasibility in various clinical research settings. |
format | Online Article Text |
id | pubmed-3816100 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-38161002013-11-04 Target dIsease-Guided placEbo-contRolled (TIGER) design: a novel method for clinical trials of acupuncture Zheng, Wenke Wang, Hui Zhang, Li Bian, Zhaoxiang Shang, Hongcai Trials Methodology BACKGROUND: At present, the design of an ideal placebo control in acupuncture studies challenges researchers. Previously devised sham acupuncture techniques have reported various imperfections; therefore, the specific effects of acupuncture cannot be accurately examined in clinical trials primarily because of interferences from the placebo effects. METHOD: Guided by evidence-based medicine (EBM) theories, we have made an initial attempt to establish a set of control methods for use in acupuncture studies, which is named the target disease-guided placebo-controlled (TIGER) design. In a trial using the TIGER design, participants suffering simultaneously from a predefined target disease and a pseudo target disease will be recruited and randomized to receive identical acupuncture intervention measures. As a result, the interventions not only appear the same but also produce the same stimulations in both groups. The patients in the treatment group will be informed of the actual target disease that the treatment aims for, whereas patients in the control group will be informed that the treatment is for the pseudotarget disease. It is speculated that no psychological response will be aroused in the control group. During data analysis, changes in the outcome measures of the patients in the control groupreveal the real therapeutic effect of acupuncture, and those of patients in the treatment group show both the real and placebo acupuncture effect. In this article, we explain how to put this design into use in a planned randomized clinical trial of acupuncture for the treatment of migraine. RESULTS: This approach can eliminate the acupuncture placebo effect in the control group that may confound trial results. It is possible to observe the specific and placebo effects of acupuncture for the target disease separately using the TIGER design. CONCLUSIONS: The proposed TIGER design has limitations. It is designed for clinical studies focusing on the specific effects of acupuncture, and it needs to be tested and verified for practicality and feasibility in various clinical research settings. BioMed Central 2013-10-29 /pmc/articles/PMC3816100/ /pubmed/24168427 http://dx.doi.org/10.1186/1745-6215-14-359 Text en Copyright © 2013 Zheng et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Methodology Zheng, Wenke Wang, Hui Zhang, Li Bian, Zhaoxiang Shang, Hongcai Target dIsease-Guided placEbo-contRolled (TIGER) design: a novel method for clinical trials of acupuncture |
title | Target dIsease-Guided placEbo-contRolled (TIGER) design: a novel method for clinical trials of acupuncture |
title_full | Target dIsease-Guided placEbo-contRolled (TIGER) design: a novel method for clinical trials of acupuncture |
title_fullStr | Target dIsease-Guided placEbo-contRolled (TIGER) design: a novel method for clinical trials of acupuncture |
title_full_unstemmed | Target dIsease-Guided placEbo-contRolled (TIGER) design: a novel method for clinical trials of acupuncture |
title_short | Target dIsease-Guided placEbo-contRolled (TIGER) design: a novel method for clinical trials of acupuncture |
title_sort | target disease-guided placebo-controlled (tiger) design: a novel method for clinical trials of acupuncture |
topic | Methodology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816100/ https://www.ncbi.nlm.nih.gov/pubmed/24168427 http://dx.doi.org/10.1186/1745-6215-14-359 |
work_keys_str_mv | AT zhengwenke targetdiseaseguidedplacebocontrolledtigerdesignanovelmethodforclinicaltrialsofacupuncture AT wanghui targetdiseaseguidedplacebocontrolledtigerdesignanovelmethodforclinicaltrialsofacupuncture AT zhangli targetdiseaseguidedplacebocontrolledtigerdesignanovelmethodforclinicaltrialsofacupuncture AT bianzhaoxiang targetdiseaseguidedplacebocontrolledtigerdesignanovelmethodforclinicaltrialsofacupuncture AT shanghongcai targetdiseaseguidedplacebocontrolledtigerdesignanovelmethodforclinicaltrialsofacupuncture |